Definity Side Effects
How can Definity Side Effects affect You? | PatientsVille.com
View and Submit Definity Side Effects
Your Definity Side Effect submission can play a very important role. Reporting your experience could help identify an unknown risk and inform other patients and health care professionals.
Record and Track Your Side Effects
It is very important to keep track of all side effects and discuss them with your doctor. If you think you may have a medical emergency, call your doctor or 911 immediately.
Most drugs have a large list of nonsevere or mild adverse effects which do not rule out continued usage. These effects depend on individual sensitivity, and can include nausea, dizziness, diarrhea, malaise, vomiting, headache, dermatitis, dry mouth, etc. Check commonly reported side effects . These can be considered a form of pseudo-allergic reaction, as not all users experience these effects; many users experience none at all.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Alternative DEFINITY Names:PERFLUTRE
Active Ingredient: PERFLUTRE
Side Effects reported to FDA: 1215. View Definity Adverse Reports
Reported deaths: 31
Reported hospitalizations: 114
Micro-bubble Contrast Agents (marketed as Definity (Perflutren Lipid Microsphere) Injectable Suspension and Optison (Perflutren Protein-Type A Microspheres for Injection)
Audience: Radiological healthcare professionals, cardiologists, hospital risk managers
[Posted 07/17/2008] FDA is updating healthcare professionals about recent changes made to the Boxed Warning, Warnings, and Contraindications sections of the prescribing information for micro-bubble contrast agents, a sterile suspension of perflutren gas microspheres, indicated for use in certain patients with suboptimal echocardiograms, to opacify the left ventricular chamber and to improve the delineation of the left ventricular endocardial border.These changes reflect conclusions of FDA reviews of information received following the addition of new Contraindications and Warnings in October 2007. The revised Boxed Warning and Warnings highlight the risk of serious cardiopulmonary reactions during or within 30 minutes following the administration of these products and recommend that high risk patients with pulmonary hypertension or unstable cardiopulmonary conditions be closely monitored during and for at least 30 minutes post administration of these contrast agents. In addition, several of the Contraindications that were added to the labeling in October, 2007 were removed because FDA determined that, in some patients, the benefits from the diagnostic information obtained through the use of Definity or Optison may outweigh the risk for serious cardiopulmonary reactions, even among some patients at particularly high risk for these reactions.
Definity Adverse Reactions
Back Pain ( 649 Reports)|Dyspnoea ( 107 Reports)|Urticaria ( 103 Reports)|Flushing ( 85 Reports)|Chest Pain ( 82 Reports)|Headache ( 71 Reports)|Muscle Spasms ( 60 Reports)|Pruritus ( 58 Reports)|Dizziness ( 55 Reports)|Pain In Extremity ( 54 Reports)|Nausea ( 46 Reports)|Arthralgia ( 40 Reports)|Hypotension ( 40 Reports)|Chest Discomfort ( 36 Reports)|Cardiac Arrest ( 33 Reports)|Hyperhidrosis ( 32 Reports)|Feeling Hot ( 29 Reports)|Rash ( 29 Reports)|Blood Pressure Increased ( 26 Reports)|Erythema ( 23 Reports)|Loss Of Consciousness ( 22 Reports)|Heart Rate Increased ( 21 Reports)|Throat Tightness ( 21 Reports)|Blood Pressure Decreased ( 20 Reports)|Neck Pain ( 20 Reports)|Respiratory Arrest ( 19 Reports)|Flank Pain ( 18 Reports)|Pain ( 18 Reports)|Musculoskeletal Pain ( 17 Reports)|Hypersensitivity ( 16 Reports)|